[go: up one dir, main page]

FI870457L - PHARMACEUTICAL PREPARATFORMER FOER STABILISERING AV INTERFERON. - Google Patents

PHARMACEUTICAL PREPARATFORMER FOER STABILISERING AV INTERFERON. Download PDF

Info

Publication number
FI870457L
FI870457L FI870457A FI870457A FI870457L FI 870457 L FI870457 L FI 870457L FI 870457 A FI870457 A FI 870457A FI 870457 A FI870457 A FI 870457A FI 870457 L FI870457 L FI 870457L
Authority
FI
Finland
Prior art keywords
stabilisering
preparatformer
foer
interferon
pharmaceutical
Prior art date
Application number
FI870457A
Other languages
Finnish (fi)
Other versions
FI86144C (en
FI86144B (en
FI870457A0 (en
Inventor
Helmut Franz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI870457A0 publication Critical patent/FI870457A0/en
Publication of FI870457L publication Critical patent/FI870457L/en
Application granted granted Critical
Publication of FI86144B publication Critical patent/FI86144B/en
Publication of FI86144C publication Critical patent/FI86144C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI870457A 1986-02-05 1987-02-03 FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTICAL PREPARATFORMER FOER TOPISK ANVAENDNING FOER STABILIZERING AV -INTERFERON. FI86144C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3603444 1986-02-05
DE19863603444 DE3603444A1 (en) 1986-02-05 1986-02-05 PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA

Publications (4)

Publication Number Publication Date
FI870457A0 FI870457A0 (en) 1987-02-03
FI870457L true FI870457L (en) 1987-08-06
FI86144B FI86144B (en) 1992-04-15
FI86144C FI86144C (en) 1992-07-27

Family

ID=6293372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870457A FI86144C (en) 1986-02-05 1987-02-03 FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTICAL PREPARATFORMER FOER TOPISK ANVAENDNING FOER STABILIZERING AV -INTERFERON.

Country Status (20)

Country Link
EP (1) EP0231816B1 (en)
JP (1) JPS62209024A (en)
KR (1) KR870007698A (en)
AT (1) ATE63823T1 (en)
AU (1) AU601712B2 (en)
CA (1) CA1295242C (en)
DD (1) DD284602A5 (en)
DE (2) DE3603444A1 (en)
DK (1) DK164202C (en)
ES (1) ES2028796T3 (en)
FI (1) FI86144C (en)
GR (1) GR3002270T3 (en)
HU (1) HU196560B (en)
IE (1) IE59697B1 (en)
IL (1) IL81472A0 (en)
NO (1) NO169638C (en)
NZ (1) NZ219169A (en)
PH (1) PH24377A (en)
PT (1) PT84243B (en)
ZA (1) ZA87793B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275804A (en) * 1986-02-25 1994-01-04 E. B. Michaels Research Associates, Inc. Process and composition for oral hygiene
DE3731255A1 (en) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilization of therapeutically active proteins in pharmaceutical preparations
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3803312A1 (en) * 1988-02-04 1989-08-10 Gerd Prof Dr Med Gross Use of an interferon-containing gel
NO179479C (en) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Process for the preparation of an intravaginal pharmaceutical preparation
ATE110571T1 (en) * 1988-05-06 1994-09-15 Toray Industries STABLE INTERFERON BETA COMPOSITION.
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
JPH07501320A (en) * 1991-10-11 1995-02-09 ギリーズ，マーク・セドリック Treatment of ocular fibrosis with interferon alpha
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
FI106465B (en) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Process for the preparation of virus-safe pharmaceutical compositions
US6923966B2 (en) 1999-04-08 2005-08-02 Schering Corporation Melanoma therapy
JP4536194B2 (en) * 2000-02-17 2010-09-01 大日本住友製薬株式会社 Stable injectable formulation
PL202918B1 (en) * 2000-03-07 2009-08-31 Rush Presbyterian St Luke Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
WO2003037375A1 (en) * 2001-11-02 2003-05-08 Sekisui Chemical Co., Ltd. Cytokine-inducing material and cytokine-inducing instrument
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
EP2435139B1 (en) * 2009-05-29 2016-10-05 Innonix Technologies, Incorporated Composition for use in decreasing the transmission of human pathogens
RU2431489C1 (en) * 2010-05-25 2011-10-20 Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий") Method of treating chronic inflammatory bowel diseases
SG11201405359YA (en) 2012-03-01 2014-09-26 Firststring Res Inc Topical gels containing alpha connexin c-terminal (act) peptides
JP6081156B2 (en) * 2012-11-15 2017-02-15 アルケア株式会社 Hydrogel
DE102012222365A1 (en) 2012-12-05 2014-06-05 Aesculap Ag Composition for use in the prophylaxis of post-surgical adhesions
WO2014199373A1 (en) * 2013-06-09 2014-12-18 Efranat Ltd. Compositions comprising gc- macrophage activating factor and uses thereof
CN110167516B (en) 2017-01-31 2022-08-30 金伯利-克拉克环球有限公司 Antibacterial composition containing benzoate and method for inhibiting bacterial growth by using same
WO2022087396A1 (en) 2020-10-22 2022-04-28 Firststring Research, Inc. Peptide formulations and ophthalmic uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (en) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト Pharmaceutical composition
JPS6069037A (en) * 1983-09-26 1985-04-19 Sunstar Inc External preparation for erythematosus
DE3484951D1 (en) * 1983-10-14 1991-09-26 Sumitomo Pharma EXTENDED PREPARATIONS WITH DELAYED DELIVERY.
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS60228422A (en) * 1984-04-26 1985-11-13 Suntory Ltd Stabilized preparation of physiologically active substance
JPS60260523A (en) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd Freeze-dried pharmaceutical composition of interferon

Also Published As

Publication number Publication date
DK164202C (en) 1992-10-19
DK164202B (en) 1992-05-25
GR3002270T3 (en) 1992-12-30
DK58387D0 (en) 1987-02-04
DK58387A (en) 1987-08-06
IE870295L (en) 1987-08-05
EP0231816A3 (en) 1987-09-23
AU601712B2 (en) 1990-09-20
EP0231816B1 (en) 1991-05-29
HU196560B (en) 1988-12-28
FI86144C (en) 1992-07-27
NO169638C (en) 1992-07-22
NO169638B (en) 1992-04-13
FI86144B (en) 1992-04-15
CA1295242C (en) 1992-02-04
IE59697B1 (en) 1994-03-23
NZ219169A (en) 1990-04-26
FI870457A0 (en) 1987-02-03
JPS62209024A (en) 1987-09-14
IL81472A0 (en) 1987-09-16
PH24377A (en) 1990-06-13
ATE63823T1 (en) 1991-06-15
NO870441D0 (en) 1987-02-04
ZA87793B (en) 1988-10-26
ES2028796T3 (en) 1992-07-16
PT84243B (en) 1989-09-14
DD284602A5 (en) 1990-11-21
DE3603444A1 (en) 1987-08-06
EP0231816A2 (en) 1987-08-12
AU6829287A (en) 1987-08-06
NO870441L (en) 1987-08-06
PT84243A (en) 1987-03-01
KR870007698A (en) 1987-09-21
DE3770280D1 (en) 1991-07-04
HUT43494A (en) 1987-11-30

Similar Documents

Publication Publication Date Title
FI870457L (en) PHARMACEUTICAL PREPARATFORMER FOER STABILISERING AV INTERFERON.
FI863362L (en) PHARMACEUTICAL COMPOSITION.
DE3783437D1 (en) MEDICINE.
FI891548A7 (en) ADMINISTERING AV MONOAMINAKRIDINER I KOLINERGISKA BRISTTILLSTAOND AV NERVCELLER.
FI871750L (en) NASAL ADMINISTRATION AV LAEKEMEDEL.
FI875326L (en) LJUSBESTRAOLNINGSNORDNING FOER MEDICINAL VAORD AV OERA.
FI873113L (en) TWEAKT MEDICINE COMPOSITION.
FI885026L (en) HAORVAORD MEDICINE.
FI875046L (en) FOERFARANDE FOER FRAMSTAELLNING AV REN DIMETYLETER.
FI872733A0 (en) PHARMACEUTICAL COMPOSITION.
FI871682A0 (en) ANGLE FOER SPOERSPAENNING AV GLASSKIVOR.
FI872313A0 (en) PHARMACEUTICAL COMPOSITION.
FI875245L (en) FOERFARANDE FOER OEKANDE AV UTSOENDRINGEN AV ADENOSIN.
NO874193D0 (en) PHARMACEUTICAL PREPARATIONS.
DE3763519D1 (en) MEDICINAL PRODUCTS.
FI874414A0 (en) CONTROLLED PHARMACEUTICAL COMPOSITION.
FI852658L (en) PHARMACEUTICAL AEMNEN.
FI881238A7 (en) PHARMACEUTICAL PREPARATION.
FI875616A0 (en) PHARMACEUTICAL BLANDNINGAR.
NO882264D0 (en) PHARMACEUTICAL PACKAGE.
FI875325A0 (en) BESTRAOLNINGSANORDNING FOER SYNBART LJUS VID MEDICINAL ANVAENDNING.
NO875121D0 (en) DRUG RING FORM.
FI865010A0 (en) PHARMACEUTICAL AEMNESKLASS.
NO874852D0 (en) PHARMACEUTICAL MIXTURES.
IT8619483A0 (en) PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT